Showing results (411-420 of 516) with videos related to
Sort By:
Pageof 52
Nature Communications|May 28, 2024
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Sonia Leonardelli, et al.The Journal of Clinical Investigation|April 10, 2008
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomasStefan Pfister, Wibke G Janzarik, Marc Remke, et al.Acta Neuropathologica|January 22, 2021
Supratentorial ependymoma in childhood: more than just RELA or YAPValentina Zschernack, Stephanie T Jünger, Martin Mynarek, et al.Seizure|February 23, 2021
Angiocentric glioma-associated seizures: The possible role of EATT2, pyruvate carboxylase and glutamine synthetaseAnna Maria Buccoliero, Chiara Caporalini, Mirko Scagnet, et al.Journal of Personalized Medicine|February 25, 2022
Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the NeuroradiologistSimona Gaudino, Carolina Giordano, Francesca Magnani, et al.Neuro-Oncology|July 3, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomideWolfgang Wick, Patrick Roth, Christian Hartmann, et al.International Journal of Cancer|October 28, 2020
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trialTheophilos Tzaridis, Niklas Schäfer, Johannes Weller, et al.Neuro-Oncology Advances|October 1, 2021
Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumorsJoshua N Baugh, Gerrit H Gielen, Dannis G van Vuurden, et al.Klinische Padiatrie|May 21, 2019
SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade GliomaAstrid K Gnekow, Daniela Kandels, Cornelis van Tilburg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumorsDamien Faury, André Nantel, Sandra E Dunn, et al.Pageof 52